Literature DB >> 23260704

Bronchiolitis obliterans syndrome, hypogammaglobulinemia, and infectious complications of lung transplantation.

Daniel C Chambers1, Belinda Davies, Ann Mathews, Stephanie T Yerkovich, Peter M Hopkins.   

Abstract

BACKGROUND: Because infection has been associated with the development of bronchiolitis obliterans syndrome (BOS), we hypothesized that post-transplant hypogammaglobulinemia would be associated with infection and BOS.
METHODS: Cross-sectional levels of serum immunoglobulins were measured on 2 occasions in our transplant cohort and models developed to explain serum immunoglobulin levels and BOS-free survival.
RESULTS: A total of 139 patients (median age, 46.6 years) were evaluated at 47 months (range, 15-74 months) after transplant, and 87 were re-evaluated at 72 months (40-107 months). Of this cohort, 44% were immunoglobulin (Ig) G deficient and levels remained stable across the study period, and 27% were IgA deficient and levels fell slightly over time (p = 0.003). Both immunoglobulin classes were lower in patients with a history of invasive fungal infection, whereas IgA levels were lower in patients with a history of community-acquired respiratory viral infection. Low IgG was independently associated with shorter BOS-free survival (hazard ratio, 0.79; 95% confidence interval, 0.71-0.88; p<0.001).
CONCLUSION: Serum immunoglobulin deficiency is common after lung transplantation and is associated with community-acquired respiratory viral infection, invasive fungal infection, and BOS.
Copyright © 2013 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23260704     DOI: 10.1016/j.healun.2012.10.006

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  4 in total

Review 1.  The lung microbiome after lung transplantation.

Authors:  Julia Becker; Valeriy Poroyko; Sangeeta Bhorade
Journal:  Expert Rev Respir Med       Date:  2014-04       Impact factor: 3.772

Review 2.  Secretory Immunoglobulin A Immunity in Chronic Obstructive Respiratory Diseases.

Authors:  Charlotte de Fays; François M Carlier; Sophie Gohy; Charles Pilette
Journal:  Cells       Date:  2022-04-13       Impact factor: 7.666

3.  Controversies and emerging topics in lung transplantation.

Authors:  David Abelson; Allan R Glanville
Journal:  Breathe (Sheff)       Date:  2018-12

4.  Intravenous immunoglobulin for hypogammaglobulinemia after lung transplantation: a randomized crossover trial.

Authors:  David J Lederer; Nisha Philip; Debbie Rybak; Selim M Arcasoy; Steven M Kawut
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.